Editing Johnson & Johnson (section)

== Business segments ==
{{Hatnote|For specific Johnson & Johnson products, see [[List of Johnson & Johnson products and services]]}}
The company's business is divided into two business segments: Innovative Medicine and MedTech.

Johnson & Johnson Innovation, LLC (JJI) is a subsidiary of Johnson & Johnson.<ref>{{Cite web |title=Innovation Centers {{!}} Johnson & Johnson Innovation |url=https://jnjinnovation.com//home |access-date=December 28, 2022 |website=jnjinnovation.com |language=en |archive-date=December 28, 2022 |archive-url=https://web.archive.org/web/20221228003425/https://jnjinnovation.com//home |url-status=dead }}</ref> JJI focuses on early-stage, [[life science]], and technology innovations to advance the company's [[research and development]] pipeline.<ref>{{Cite web |last=Waldron |first=James |date=September 20, 2022 |title=Johnson & Johnson opens 400-person R&D facility to strengthen Bay Area presence |url=https://www.fiercebiotech.com/biotech/jjs-rd-units-move-200k-sq-ft-facility-strengthen-bay-area-presence |access-date=December 28, 2022 |website=Fierce Biotech |language=en}}</ref> JJI provides startups with sourcing, infrastructure, and capital equipment at JLABS, financing & venture capital at JJDC, Inc., and collaborations leading to the potential development of medical device technologies, pharmaceuticals, and therapeutics.<ref>{{Cite web |last=Waldron |first=James |date=September 20, 2022 |title=Johnson & Johnson opens 400-person R&D facility to strengthen Bay Area presence |url=https://www.fiercebiotech.com/biotech/jjs-rd-units-move-200k-sq-ft-facility-strengthen-bay-area-presence |access-date=December 28, 2022 |website=Fierce Biotech |language=en}}</ref> There are 4 JJI Innovation Centers located in London,<ref>{{Cite web |last=Levin |first=Jennifer |date=March 13, 2013 |title=Johnson & Johnson Announces Opening of London Innovation Centre |url=https://www.fiercebiotech.com/biotech/johnson-johnson-announces-opening-of-london-innovation-centre |access-date=December 28, 2022 |website=Fierce Biotech |language=en}}</ref> Shanghai, [[Boston]] (Cambridge),<ref>{{Cite web |title=What If We Could Stop Lung Cancer Before It Starts? |url=https://www.bu.edu/articles/2019/stoping-lung-cancer-before-it-starts/ |access-date=December 28, 2022 |website=Boston University |language=en}}</ref> and the [[San Francisco Bay Area]]. There are 13 JLABS incubators located in the Bay Area (San Francisco and [[South San Francisco, California|South San Francisco]]),<ref>{{Cite web |title=J&J opens new research hub near San Francisco |url=https://www.biopharmadive.com/news/johnson-johnson-research-facility-open-san-francisco/632237/ |access-date=December 28, 2022 |website=BioPharma Dive |language=en-US}}</ref> Belgium ([[Beerse]]), Boston (Cambridge and Lowell), [[Houston]] (TMC),<ref>{{Cite web |last=Lawrence |first=Stacy |date=October 18, 2016 |title=J&J to create new Texas center to develop 'breakthrough' med tech |url=https://www.fiercebiotech.com/medical-devices/j-j-to-create-new-texas-center-to-develop-breakthrough-med-tech |access-date=December 28, 2022 |website=Fierce Biotech |language=en}}</ref> New York City, [[Philadelphia]], [[San Diego]], Shanghai, [[Toronto]], and Washington, D.C.<ref>{{Cite web |title=Innovation Centers {{!}} Johnson & Johnson Innovation |url=https://jnjinnovation.com//home |access-date=December 28, 2022 |website=jnjinnovation.com |language=en |archive-date=December 28, 2022 |archive-url=https://web.archive.org/web/20221228003425/https://jnjinnovation.com//home |url-status=dead }}</ref>

{| class="wikitable"
|+Johnson & Johnson business segments
! Innovative Medicine<ref name="Pharmaceutical Products">{{Cite web|url=https://www.jnj.com/healthcare-products/prescription|title=Pharmaceutical Products|website=Content Lab – U.S.}}</ref>!! MedTech<ref name="auto1">{{Cite web |title=MedTech |url=https://www.jnj.com/healthcare-products/medtech |website=Johnson & Johnson MedTech}}</ref>
|-
|Immunology<br />Cardiovascular & metabolic disease<br />Pulmonary hypertension<br />Infectious diseases & vaccines<br />Neuroscience<br />Oncology||Interventional solutions<br />Orthopaedics<br />Surgery (general & advanced)<br />Vision
|}

=== Innovative Medicine ===
The Innovative Medicine (formerly known as pharmaceuticals) segment is focused on six therapeutic areas: [[immunology]] (rheumatoid arthritis, inflammatory bowel disease and psoriasis); [[infectious diseases]] (HIV/AIDS); [[neuroscience]] (mood disorders, neurodegenerative disorders and schizophrenia); [[oncology]] (solid tumours including lung cancer, prostate cancer and bladder cancer, and hematologic malignancies); [[cardiovascular]], [[metabolism]], [[retina]] (thrombosis and diabetes), and [[pulmonary hypertension]] (pulmonary arterial hypertension).<ref name="Pharmaceutical Products"/><ref name="auto">{{Cite web |title=0000200406-21-000008 {{!}} 10-K {{!}} Johnson & Johnson |url=https://johnsonandjohnson.gcs-web.com/sec-filings/sec-filing/10-k/0000200406-21-000008/ |access-date=February 23, 2021 |website=johnsonandjohnson.gcs-web.com |language=en |archive-date=November 29, 2022 |archive-url=https://web.archive.org/web/20221129113411/https://johnsonandjohnson.gcs-web.com/sec-filings/sec-filing/10-k/0000200406-21-000008 |url-status=dead }}</ref>

=== MedTech ===
The Cardiovascular & Specialty Solutions Group includes [[electrophysiology]] products that diagnose and treat cardiac arrhythmias; devices used in the endovascular treatment of hemorrhagic and ischemic stroke; solutions that focus on [[Mentor (company)|breast reconstruction and aesthetics]], and ear, [[Acclarent|nose and throat]] procedures.<ref>{{Cite news|date=December 1, 2008|title=J&J to buy breast implant firm Mentor for $1.1 billion|language=en|work=[[Reuters]]|url=https://www.reuters.com/article/us-johnsonjohnson-mentor-idUSTRE4B03JO20081201|access-date=September 28, 2021}}</ref>

The [[DePuy Synthes|orthopaedics]] portfolio is composed of specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELY digital surgery portfolio.<ref>{{Cite web|title=DePuy Synthes Product, Inc. Leases Palm Beach Gardens Office Space Expanding South Florida Footprint|url=https://profilemiamire.com/miamirealestate/2021/9/8/depuy-synthes-product-inc-leases-palm-beach-gardens-office-space-expanding-south-florida-footprint|access-date=September 28, 2021|website=PROFILE Miami|date=September 8, 2021 |language=en-US}}</ref>

The [[Ethicon|surgery portfolio]] includes advanced surgical innovations and solutions such as [[Suture (anatomy)|sutures]], staplers, energy devices, and advanced [[hemostat]]s along with interventional ablation, surgical robotics, and digital solutions.<ref>{{Cite web|date=January 10, 2016|title=ETHICON History|url=http://www.ethiconproducts.co.uk/about/ethicon-history|access-date=September 28, 2021|archive-url=https://web.archive.org/web/20160110154950/http://www.ethiconproducts.co.uk/about/ethicon-history|archive-date=January 10, 2016}}</ref>

The [[Johnson & Johnson Vision]] portfolio includes [[contact lens|contact lenses]], [[intraocular lens]], automated treatment for dry eye, and four brands of laser vision correction systems.<ref name="auto1"/><ref name="auto"/>